Nano-Ditech Corporation

Click Here To EMAIL INQUIRY
Web: http://www.nanoditech.com
E-Mail:
Address: 7 Clarke Drive, Suite 3, Cranbury, New Jersey 08512, USA
Phone: +1-(609)-409-0700 | Fax: +1-(609)-409-0722 | Map/Directions >>

Profile: Nano-Ditech Corp specializes in the development and manufacture of high quality rapid immuno-diagnostic products to serve the point-of-care marketplace including medical professionals, physicians, clinical laboratories & hospitals. We focus on rapid point-of-care testing (POCT) immunoassays for the detection of drugs of abuse and cardiac markers in the emergency department. The Nano-Check™ AMI cardiac panel provides accurate and prompt identification of myocardial injury & valuable prognostic information. It allows quick access to cardiac marker status that allows healthcare professionals to quickly initiate treatment to patients experiencing chest pain. It assures cost-effective and timely patient care. It is a simple one-step, fast turn-around, and low cost diagnostic device that delivers accurate results in 10-15 minutes. It is a lateral flow immunoassay for three key cardiac markers (TnI, CK-MB, Myo) in plasma, serum or whole blood. The Nano-Check™ DAT test is a membrane based one-step immunoassay that detects the presence of 12 different illicit drugs in 5-10 minutes using 80 µl of sample urine.

FDA Registration Number: 3005174594

17 Products/Services (Click for related suppliers)

• Cannabinoids Enzyme Immunoassay Test (FDA Code: LDJ / 862.3870)

A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds includedelta -9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use.

• Cardiac Markers

• Cardiac Panel

• Cocaine and Cocaine Metabolites Enzyme Immunoassay Test (FDA Code: DIO / 862.3250)

A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.

• CPK Isoenzymes Chromatographic Separation Test (FDA Code: JHT / 862.1215)

A creatine phosphokinase/creatine kinase or isoenzymes test system is a device intended to measure the activity of the enzyme creatine phosphokinase or its isoenzymes (a group of enzymes with similar biological activity) in plasma and serum. Measurements of creatine phosphokinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction and muscle diseases such as progressive, Duchenne-type muscular dystrophy.

• Drugs Of Abuse Test Kits

• Drugs of Abuse Test Strips

• Immunoassays

• Immunodiagnostic Test Kits

• Metamphetamine Thin Layer Chromatography Test (FDA Code: DJC / 862.3610)

A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose.

• Multi-Drug Screen Panel Test

• Myoglobin (FDA Code: DDR / 866.5680)

A myoglobin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the myoglobin (an oxygen storage protein found in muscle) in serum and other body fluids. Measurement of myoglobin aids in the rapid diagnosis of heart or renal disease.

• Nocotine And Nicotine Metabolites Enzyme Immunoassasy (FDA Code: MKU / 862.3220)

A carbon monoxide test system is a device intended to measure carbon monoxide or carboxyhemoglobin (carbon monoxide bound to the hemoglobin in the blood) in blood. Measurements obtained by this device are used in the diagnosis and treatment of or confirmation of carbon monoxide poisoning.

• Opiates Enzyme Immunoassay Test (FDA Code: DJG / 862.3650)

An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.

• Phencyclidine Enzyme Immunoassay (FDA Code: LCM)

• Reflectance Densitometer/Scanner (FDA Code: JQT / 862.2400)

A densitometer/scanner (integrating, reflectance, thin-layer chromatography, or radiochromatogram) for clinical use is device intended to measure the concentration of a substance on the surface of a film or other support media by either a photocell measurement of the light transmission through a given area of the medium or, in the case of the radiochromatogram scanner, by measurement of the distribution of a specific radio-active element on a radiochromatogram.

• Troponin Subunit Enzymatic Method (FDA Code: MMI / 862.1215)